Main Library
The Pharmacy Quality Alliance (PQA) has a new pharmacy performance measure that evaluates adherence to medications for diabetes, hypertension (renin angiotensin system antagonists) and high cholesterol (statins), through a single composite measure.1
You may be thinking, “I thought PQA already had member-endorsed adherence measures for these medications.” The answer is a bit nuanced.
There are 3 similar PQA adherence measures used in the Medicare Part D Star Ratings that were specifically developed, tested and specified for health plan performance measurement.2 There are notable differences between those health plan measures and our new pharmacy measure.
Endorsed by PQA members in December after a rigorous development and testing process, the new composite pharmacy adherence measure is a major step forward in our work to develop standard pharmacy performance measures focused on improving patient care.